DETERMINATION OF OFLOXACIN, A NEW OXAZINE DERIVATIVE IN HUMAN-SERUM, URINE, AND BILE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：22

作者：

CARLUCCI, G

GUADAGNI, S

PALUMBO, G

机构：

[1] UNIV AQUILA,DEPT SURG CLIN,I-67100 AQUILA,ITALY

[2] UNIV AQUILA,DEPT INTERNAL MED & PUBL HLTH,CHAIR PHARMACOL,I-67100 AQUILA,ITALY

来源：

JOURNAL OF LIQUID CHROMATOGRAPHY | 1986年 / 9卷 / 11期

关键词：

D O I：

10.1080/01483918608076882

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：2539 / 2547

页数：9

共 9 条

[1]

[Anonymous], 1984, CHEMOTHERAPY, V32, P118

[2]

GUADAGNI S, 1985, EUR REV MED PHARM SC, V7, P111

[3]

MIDORI T, 1984, CHEMOTHERAPY TOKYO, V32, P59

[4] INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE [J].

SATO, K ;

MATSUURA, Y ;

INOUE, M ;

UNE, T ;

OSADA, Y ;

OGAWA, H ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :548-553

[5] COMPARISON OF THE ANTI-BACTERIAL INVITRO AND INVIVO ACTIVITY OF OFLOXACIN (HOE-280 DL-8280) AND NALIDIXIC-ACID ANALOGS [J].

SEIBERT, G ;

LIMBERT, M ;

KLESEL, N .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) :548-553

[6]

Sudo K, 1984, CHEMOTHERAPY TOKY S1, V32, P1203

[7]

TAKESHI N, 1984, CHEMOTHERAPY TOKYO, V32, P62

[8]

VONSEIBERT G, 1984, ARZNEIM FORSCH DRUG, V34, P1552

[9]

YASAKI O, 1984, CHEMOTHERAPY TOKYO, V32, P90

← 1 →